Latest news with #PAI
Arab Times
3 days ago
- Business
- Arab Times
Kuwait's Forgotten Tyre Graveyard: Push for Urgent Cleanup Plan
KUWAIT CITY, July 26: Municipal Council member Alia Al-Farsi has submitted a question to the executive body of Kuwait Municipality regarding tyre landfills and dumping sites, pointing out that Kuwait has scarce and undiversified natural resources, while it has large quantities of waste that can be utilised in the economic sector. Al-Farsi said the Environmental Affairs Committee in the council discussed this issue in its first workshop -- held on June 26, 2024 -- under the title, 'Tyre Landfills and Dumping Sites and their Impact on Public Health and Environmental Safety - Current Situation and Sustainable Solutions,' which resulted in the issuance of a set of urgent and long-term recommendations. She included in her question the most important recommendations presented at the workshop -- the need for coordination between the Municipality, Environment Public Authority (EPA) and Public Authority for Industry (PAI) to gradually eliminate tyre accumulation, particularly at the Kilometer 65 site in Salmi, with the participation of factories licensed by PAI and Kuwaiti entrepreneurs approved by the Municipality. She said this should be part of a comprehensive plan that includes studying the specifications of the accumulated tyres (both new and old) and the mechanism for distributing them to treatment facilities, under the supervision of the Municipality and according to a clear timetable. She added that the plan must also include meeting the requirements of the Kuwait Fire Force (KFF) at tyre collection sites, such as establishing temporary water basins, developing a comprehensive plan to manage tyre disposal in line with sustainable development goals, and rehabilitating waste transporters in light of the new regulations for municipal waste management and public hygiene. She enumerated the other recommendations as follows: Promote modern tyre processing methods; Prepare a procedures manual for the use of recycled building materials in coordination with Kuwait Institute for Scientific Research (KISR), Ministry of Public Works and Kuwait University; Specify legislative frameworks through the Regulations Review Committee at the Municipality; Monitor the results of experiments conducted by some entities using rubber asphalt extracted from tyres, in preparation for developing technical specifications and expanding the scope of application in road projects; Invest in recycled waste within road maintenance contracts at the Ministry of Public Works; Support and encourage the private sector to implement projects that promote sustainable development and the green economy Al-Farsi pointed out that more than a year had passed since the issuance of these recommendations, which prompted her to present a series of questions to the executive body in the Municipality, about the measures taken regarding the tyres landfill in Salmi (Kilometer 65) and the extent of the commitment of the Municipality to implement the recommendations; especially concerning the disposal of tyre waste in line with the sustainable development goals. She also inquired about the mechanism followed in measuring and managing the quantities of accumulated tyres, as well as the increase and disposal rates.
Business Standard
21-07-2025
- Business
- Business Standard
Stock Alert: Reliance Industries, HDFC Bank, ICICI Bank, Yes Bank, Dr Reddys Lab
Securities In F&O Ban: Angel One, Bandhan Bank, Hindustan Copper and RBL Bank shares are banned from F&O trading on 21 July 2025. Upcoming Results: Agi Greenpac, CIE Automotive India, CRISIL, DCM Shriram, Dodla Dairy, Eternal, Ganesh Housing Corporation, Havells India, IDBI Bank, Latent View Analytics, Mahindra Logistics, Oberoi Realty, Parag Milk Foods, PNB Housing Finance, Rajratan Global Wire, Sagar Cements, UCO Bank, UltraTech Cement will announce their result later today. Stocks to Watch: Reliance Industries' (RIL) profit after tax and share of profit/(loss) of associates & JVs increased by 76.5% year-on-year (Y-o-Y) to Rs 30,783 crore in Q1 June 2025. The company's gross revenue increased by 6% Y-o-Y to Rs 273,252 crore in Q1 June 2025. Yes Bank reported 59.43% surge in standalone net profit to Rs 801.07 crore in Q1 FY26 as against Rs 502.43 ecrore posted in Q1 FY25. The banks total income rose 4.82% YoY to Rs 9,348.11 crore in the quarter ended 30 June 2025. ICICI Bank reported a standalone net profit of Rs 12,768.21 crore in Q1 FY26, up 15.45% as against Rs 11,059.11 crore posted in Q1 FY25. Total income increased 11.85% year on year (YoY) to Rs 51,451.81 crore in Q1 FY26. HDFC Bank's profit after tax (PAT) for the quarter ended June 2025 was at Rs 18,155.21 crore, a growth of 12.24% over the quarter ended June 2024. Net interest income (interest earned less interest expended) for the quarter ended June 2025 grew by 5.4% to Rs 31,440 crore from Rs 29,840 crore for the quarter ended June 2024. RBL Banks standalone net profit tumbled 46.07% to Rs 200.33 crore in Q1 FY26 as against Rs 371.52 crore posted in Q1 FY25. However, total income increased 4.85% year on year (YoY) to Rs 4,510.57 crore in the quarter ended 30 June 2025. Firstsource Solutions wholly owned subsidiary, Firstsource Solutions UK has executed a share purchase agreement with Pastdue Credit Solutions (PDC) to acquire 100% stake in PDC for a consideration of GBP 22 million, including upfront payment & earnouts. Dr Reddys Laboratories announced that United States Food & Drug Administration (USFDA) completed a GMP and a Pre-Approval Inspection (PAI) at its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh, India. USFDA issued a Form 483 with 7 observations.
News18
20-07-2025
- Business
- News18
Dr Reddys gets seven observations from USFDA for Andhra plant
New Delhi, Jul 20 (PTI) Dr Reddy's Laboratories has received a Form 483 with seven observations from the US health regulator for its Srikakulam-based plant in Andhra Pradesh, according to a regulatory filing. The US Food and Drug Administration (USFDA) conducted the GMP and a Pre-Approval Inspection (PAI) at the formulations manufacturing facility from July 10 to 18, 2025, the Hyderabad-based drug major said in the filing. 'We have been issued a Form 483 with seven observations, which we will address within the stipulated timeline," it added. As per the USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food, Drug and Cosmetic (FD&C) Act and related Acts. PTI MSS BAL BAL Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
20-07-2025
- Business
- Time of India
Dr Reddy's gets seven observations from USFDA for Andhra plant
Dr Reddy's Laboratories has received a Form 483 with seven observations from the US health regulator for its Srikakulam-based plant in Andhra Pradesh , according to a regulatory filing. The US Food and Drug Administration ( USFDA ) conducted the GMP and a Pre-Approval Inspection (PAI) at the formulations manufacturing facility from July 10 to 18, 2025, the Hyderabad-based drug major said in the filing. Explore courses from Top Institutes in Select a Course Category Management healthcare Degree Leadership Project Management Others Data Science Design Thinking CXO Cybersecurity Data Science MCA PGDM MBA Operations Management Data Analytics Digital Marketing Product Management others Public Policy Technology Healthcare Finance Artificial Intelligence Skills you'll gain: Duration: 11 Months IIM Kozhikode CERT-IIMK General Management Programme India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta CERT-IIMC APSPM India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK GMPBE India Starts on undefined Get Details "We have been issued a Form 483 with seven observations, which we will address within the stipulated timeline," it added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 Most Beautiful Female Athletes in the World Click Here Undo As per the USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food, Drug and Cosmetic (FD&C) Act and related Acts.
Business Upturn
18-07-2025
- Business
- Business Upturn
Dr. Reddy's receives 7 observations from USFDA after inspection at Srikakulam plant
By Aditya Bhagchandani Published on July 18, 2025, 18:21 IST Dr. Reddy's Laboratories Ltd. announced on July 18 that the United States Food & Drug Administration (USFDA) has completed a Good Manufacturing Practice (GMP) and Pre-Approval Inspection (PAI) at its formulations manufacturing facility FTO 11, located in Srikakulam, Andhra Pradesh. According to the company's filing with stock exchanges, the inspection was conducted over eight days, from July 10 to July 18, 2025. At the conclusion of the inspection, the USFDA issued a Form 483 with seven observations. Dr. Reddy's stated that it would address the observations within the stipulated timeline, as per regulatory requirements. The company said the disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and is meant for public record and investor information. The Hyderabad-headquartered pharmaceutical major operates several manufacturing facilities in India and abroad, and this development comes as part of its routine regulatory inspections for ongoing compliance and product approvals. Disclaimer: This information is based solely on the company's official disclosure dated July 18, 2025. Business Upturn or the author is not liable for any actions taken based on this information. Investors are advised to independently verify and consult financial advisors before making investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
